References
- Sipahi OR. Economics of antibiotic resistance. Expert Rev Anti Infect Ther. 2008 Aug;6(4):523–539. doi: 10.1586/14787210.6.4.523
- Dyar OJ, Beović B, Vlahović-Palčevski V, et al. How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther. 2016 Apr;14(4):403–413. doi: 10.1586/14787210.2016.1151353
- Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022 Feb;399(10325):629–655. doi: 10.1016/S0140-6736(21)02724-0
- WHO. New report calls for urgent action to avert antimicrobial resistance crisis. 2019. [cited 2023 May 19]. Available from: https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis
- Harvey EJ, De Brún C, Casale E, et al. Influence of factors commonly known to be associated with health inequalities on antibiotic use in high-income countries: a systematic scoping review. J Antimicrob Chemother. 2023 Apr;78(4):861–870. doi: 10.1093/jac/dkad034
- Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci. 2018;115(15):E3463–E3470. doi: 10.1073/pnas.1717295115
- Ocan M, Obuku EA, Bwanga F, et al. Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries. BMC Public Health. 2015;15(1):742. doi: 10.1186/s12889-015-2109-3
- Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022. eClinicalmedicine. 2023 Mar;57:101848. doi: 10.1016/j.eclinm.2023.101848
- Chokshi A, Sifri Z, Cennimo D, et al. Global contributors to antibiotic resistance. J Glob Infect Dis. 2019;11(1):36–42. doi: 10.4103/jgid.jgid_110_18
- Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6(1):47. doi: 10.1186/s13756-017-0208-x
- Manikam L, Bou Karim Y, Boo YY, et al. Operationalising a One health approach to reduce the infection and antimicrobial resistance (AMR) burden in under-5 year old urban slum dwellers: the childhood infections and pollution (CHIP) consortium. One Heal. 2020;10:100144. doi: 10.1016/j.onehlt.2020.100144
- Iskandar K, Molinier L, Hallit S, et al. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021;10(1):63. doi: 10.1186/s13756-021-00931-w
- Knobler SL, Lemon SM, Najafi M, et al. editors; Institute of Medicine (US) Forum on Emerging Infections. The resistance phenomenon in microbes and infectious disease vectors: Implications for human health and strategies for Containment: workshop summary. 2003 [cited 2023 Jun 22]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK97126/
- Chaitkin M, McCormick S, Alvarez-Sala Torreano J, et al. Estimating the cost of achieving basic water, sanitation, hygiene, and waste management services in public health-care facilities in the 46 UN designated least-developed countries: a modelling study. Lancet Glob Health. 2022 Jun;10(6):e840–e849. doi: 10.1016/S2214-109X(22)00099-7
- Wajid S, Siddiqui NA, Mothana RA, et al. Prevalence and practice of unused and expired medicine-A community-based study among Saudi adults in Riyadh, Saudi Arabia. Biomed Res Int. 2020;2020:6539251. doi:10.1155/2020/6539251
- Karimi KJ, Ahmad A, Duse A, et al. Prevalence of antibiotic use and disposal at household level in informal settlements of Kisumu, Kenya. Int J Environ Res Public Health. 2022 Dec;20(1):287. doi: 10.3390/ijerph20010287
- Coffey KC. Is there a role for expired medications in developing countries? Clin Pediatr. 2012 Jun;52(1):7–9. doi: 10.1177/0009922812448956
- Cuevas C, Batura N, Wulandari LPL, et al. Improving antibiotic use through behaviour change: a systematic review of interventions evaluated in low- and middle-income countries. Health Policy Plan. 2021 Jun;36(5):594–605. doi: 10.1093/heapol/czab021
- Bokhary H, Pangesti KNA, Rashid H, et al. Travel-related antimicrobial resistance: a systematic review. Trop Med Infect Dis. 2021 Jan;6(1):11. doi: 10.3390/tropicalmed6010011
- Turner NA, Sharma-Kuinkel BK, Maskarinec SA, et al. Methicillin-resistant staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019 Apr;17(4):203–218. doi: 10.1038/s41579-018-0147-4
- Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016 Feb;3(1):15–21. doi: 10.1177/2049936115621709
- Yassine HM, Shah Z. How could artificial intelligence aid in the fight against coronavirus? Expert Rev Anti Infect Ther. 2020 Jun;18(6):493–497. doi: 10.1080/14787210.2020.1744275